Modular Medical Launches Pivot Insulin Delivery System Across Five Key U.S. Markets
Modular Medical Announces Independent Study Supports Favorable Payor Receptivity To Pivot's Differentiated Design, Simplified User Experience
Modular Medical Survey Shows 97% Of Injection Users Open To Pump Therapy; Company Advancing Pivot Tubeless Insulin Patch Pump, To Present At ADCES Conference August 7‑10
EXCLUSIVE: Modular Medical Advances Commercial Rollout With First Active Users Of Pivot Insulin Pump
Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements
Modular Medical Files Series Of Software Enhancements To Its PivotTM Insulin Delivery System To FDA
Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump
Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps
Modular Medical Begins Shipping Its Pivot Tubeless Insulin Patch Pump To Physician Offices For Training
Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial Expansion
EXCLUSIVE: Modular Medical Transitions To Commercial Stage With Pivot Insulin Pump Launch
Modular Medical Launches New Website for Pivot Tubeless Insulin Patch Pump
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026
Modular Medica shares are trading lower after the company announced a $3.4 million registered direct offering of 750,000 shares at $4.50 per share.
Reported Sunday, Modular Medical Prices Registered Direct Offering Of 750,000 Shares At $4.50 Per Share For Gross Proceeds Of ~$3.4M
Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock
Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.